Market Cap
$25.13 Billion
USD as of July 1, 2025
| Company | Market Cap (USD) | 
|---|---|
|  Thermo Fisher Scientific | $162.07 B | 
|  Danaher | $144.92 B | 
|  Siemens Healthineers AG | $64.17 B | 
|  Lonza Group Ltd | $49.67 B | 
|  IDEXX Laboratories, Inc. | $43.99 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 United States
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Diagnostics & Research
                            United States
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Diagnostics & Research
                     United States Healthcare
                                United States Healthcare
                        
                             United States Diagnostics & Research
                            United States Diagnostics & Research
                    
                    The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.